With today’s aging population in the United States, we are experiencing an increased occurrence of cardiovascular disease including heart failure, degenerative valve disease and atrial fibrillation. These clinical challenges, along with changes in healthcare economics and standards, require efficient, effective and streamlined diagnostic solutions. These solutions must deliver critical added benefits including:
 

Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB). 

At the IEEE medical Imaging Conference (MIC) in November, ContextVision co-presented with Texas Instruments and High Performance Consulting on new research on 3-D adaptive filtering.

Medtronic's roughly $43 billion acquisition and merger with Covidien has been widely discussed in the media for its U.S. Federal tax implications, but it's also creating a stronger leading player in one of the fastest growing device markets, according to Kalorama Information. 

Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients worldwide

Research and Markets has announced the addition of the "MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts" report to their offering

Volcano Corp. announced that more than 1,000 systems have been activated with its instant wave-Free Ratio (iFR) Modality software, featuring a simplified workflow and reduced need for hyperemic agents.

Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-sponsored REPLACE Registry was the first worldwide study to examine complications related to pacemaker or implantable cardioverter defibrillator (ICD) replacement.

Minneapolis Heart Institute Foundation (MHIF) researchers have performed two implants of the Lotus Cardiac Valve System as part of the REPRISE III clinical trial. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now